tiprankstipranks
Trending News
More News >
Biontech Se Sponsored Adr (BNTX)
NASDAQ:BNTX
US Market

BioNTech SE (BNTX) Financial Statements

Compare
4,760 Followers

BioNTech SE Financial Overview

BioNTech SE's market cap is currently $26.21B. The company's EPS TTM is $-0.13966968; its P/E ratio is -41.43; BioNTech SE is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 2.75B€ 3.82B€ 17.31B€ 18.98B€ 482.30M
Gross Profit€ 2.21B€ 3.22B€ 14.32B€ 16.07B€ 423.00M
Operating Income€ -1.31B€ 690.40M€ 12.64B€ 15.28B€ -82.40M
EBITDA€ -367.10M€ 1.38B€ 13.10B€ 15.00B€ -105.10M
Net Income€ -665.30M€ 930.30M€ 9.43B€ 10.29B€ 15.20M
Balance Sheet
Cash & Short-Term Investments€ 16.78B€ 16.55B€ 14.06B€ 2.07B€ 1.35B
Total Assets€ 22.53B€ 23.01B€ 23.28B€ 15.83B€ 2.32B
Total Debt€ 254.20M€ 219.10M€ 212.20M€ 301.50M€ 240.10M
Net Debt€ -9.51B€ -11.44B€ -13.66B€ -1.39B€ -970.10M
Total Liabilities€ 3.12B€ 2.76B€ 3.22B€ 3.94B€ 946.80M
Stockholders' Equity€ 19.41B€ 20.25B€ 20.06B€ 11.89B€ 1.37B
Cash Flow
Free Cash Flow€ -244.60M€ 4.67B€ 13.21B€ 735.70M€ -98.90M
Operating Cash Flow€ 207.70M€ 5.37B€ 13.58B€ 889.70M€ -13.50M
Investing Cash Flow€ -2.08B€ -6.95B€ -35.30M€ -566.10M€ -144.80M
Financing Cash Flow€ -45.90M€ -778.60M€ -1.42B€ 94.20M€ 894.70M
Currency in EUR

BioNTech SE Earnings and Revenue History

BioNTech SE Debt to Assets

BioNTech SE Cash Flow

BioNTech SE Forecast EPS vs Actual EPS